文献速递产科母胎医学

鼓励步行活动对早产前胎膜早破期待治疗潜伏期的影响:一项随机对照试验(AMBLE)

Ambulation for latency during expectant management of preterm prelabor rupture of membranes: a randomized controlled trial (AMBLE).
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-11-08

该多中心非盲随机对照试验将100名孕23 0/7至35 0/7周、计划至少7天后分娩的早产前胎膜早破住院患者随机分为鼓励每日步行至少2000步组与常规活动组。干预组潜伏期中位数9天,常规组6天,干预增加潜伏期的后验概率为65%;新生儿不良结局复合指标相对风险0.55,干预获益后验概率99%。

要点

  • 鼓励每日步行至少2000步的干预组潜伏期中位数9天,常规活动组6天,增加潜伏期的后验概率为65%。
  • 新生儿不良结局复合指标相对风险0.55(95%可信区间0.32-0.82),干预获益后验概率99%。
  • 干预组母亲应激评分较基线的下降幅度大于常规组,后验概率94%,平均组间差异3.24分。

核心结论

  • 早产前胎膜早破患者被随机分配接受步行鼓励后,分娩潜伏期延长,新生儿结局及心理健康结局改善,母亲临床结局与常规护理相似。

研究设计与样本

  • 多中心非盲两臂随机对照试验,纳入孕23 0/7至35 0/7周、住院期待治疗且计划至少7天后分娩的早产前胎膜早破患者。
  • 100名符合条件者被随机分组,失访后95名纳入分析;干预组通过口头及Fitbit提醒鼓励每日达到2000步,常规组允许自由活动、不设步数目标或提醒。
  • 采用意向性分析,在贝叶斯框架下使用中性先验(事先假定任一臂潜伏期更长的可能性为50:50)。
  • 需100名受试者以达到80%把握度,在75%贝叶斯概率确定性下证明4天潜伏期差异。

主要发现

  • 随机分组时孕周:干预组29 3/7周(四分位距26 2/7至31 5/7),常规组27 4/7周(四分位距25 4/7至29 6/7)。
  • 每日步数中位数:干预组1690步(四分位距1031-2641),常规组1338步(四分位距784-1913)。
  • 潜伏期中位数:干预组9天(四分位距4-17),常规组6天(四分位距2-14)。
  • 主要分析显示干预增加潜伏期相对常规护理的后验概率为65%(后验相对风险1.09;95%可信区间0.70-1.71)。
  • 新生儿不良结局复合指标相对风险0.55(95%可信区间0.32-0.82),干预获益后验概率99%;母亲不良结局复合指标相对风险0.94(95%可信区间0.72-1.20),干预获益后验概率70%;干预组母亲应激评分自基线至分娩前下降幅度大于常规组的后验概率94%(平均组间差异3.24分,95%可信区间-7.23至0.79)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Individuals hospitalized with preterm prelabor rupture of membranes are often advised to limit their activity or adhere to bed rest. Some evidence suggests that greater activity is associated with longer latency and improved outcomes, but no high-quality evidence from a randomized controlled trial exists. OBJECTIVE: This study aimed to evaluate whether encouragement to ambulate at least 2000 steps daily affects latency among individuals with preterm prelabor rupture of membranes compared with usual care. STUDY DESIGN: This was a multisite unblinded, 2-arm randomized trial of individuals at 23 0/7 to 35 0/7 weeks of gestation undergoing inpatient expectant management of preterm prelabor rupture of membranes with planned delivery at least 7 days away. Each participant wore a Fitbit Inspire that tracked steps. The intervention arm was encouraged (verbal and Fitbit-based reminders) to reach a goal of 2000 steps per day. The usual-care arm was allowed ad libitum activity with no step goal or reminders. The primary outcome was latency (days) from randomization to delivery. Secondary analyses included composite neonatal and maternal clinical outcomes and maternal mental health survey results. Statistical analyses were conducted with an intent-to-treat approach under a Bayesian framework using neutral priors (a priori assumed 50:50 likelihood of longer latency in either arm). A total of 100 participants were required to have 80% power to demonstrate a 4-day difference in latency with 75% certainty (Bayesian probability). RESULTS: Among 163 eligible individuals, 100 (61%) were randomized, and after loss to follow-up, 95 were analyzed. Gestational age at randomization was 29 3/7 weeks (interquartile range, 26 2/7 to 31 5/7) in the intervention arm and 27 4/7 weeks (interquartile range, 25 4/7 to 29 6/7) in the usual-care arm. Median step counts were 1690 per day in the intervention arm (interquartile range, 1031-2641) and 1338 per day in the usual-care arm (interquartile range, 784-1913). Median days of latency were 9 days in the intervention arm (interquartile range, 4-17) and 6 days in the usual-care arm (interquartile range, 2-14). The primary analysis indicated a 65% posterior probability that the intervention increased latency relative to usual care (posterior relative risk, 1.09; 95% credible interval, 0.70-1.71). The relative risk was 0.55 (95% credible interval, 0.32-0.82) for the composite neonatal adverse outcome, with 99% posterior probability of intervention benefit, and was 0.94 (95% credible interval, 0.72-1.20) for the composite maternal adverse outcome, with 70% posterior probability of intervention benefit. There was a 94% posterior probability of the intervention arm having a greater decrease in maternal stress score from baseline to before delivery compared with the usual-care arm (mean arm difference, 3.24 points [95% credible interval, -7.23 to 0.79]). Adjustment for gestational age at randomization had minimal impact on secondary outcome results. CONCLUSION: Individuals with preterm prelabor rupture of membranes randomized to encouragement to ambulate had a longer latency to delivery and improved neonatal and mental health outcomes, with similar maternal clinical outcomes compared with usual care.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Pineles BL, Vial M, Castro T, et al. Ambulation for latency during expectant management of preterm prelabor rupture of membranes: a randomized controlled trial (AMBLE). Am J Obstet Gynecol MFM. 2023. PMID: 37944668. doi:10.1016/j.ajogmf.2023.101218

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。